Gain Therapeutics, Inc. (GANX)

NASDAQ: GANX · IEX Real-Time Price · USD

1.210

-0.010 (-0.82%)

At close: Jul 19, 2024, 4:00 PM

1.330

+0.120 (9.92%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

Gain Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	0	0.06	0.14	0.16	0.03	0.04	Upgrade
Revenue Growth (YoY)	-	-60.62%	-15.08%	471.29%	-30.07%	100.40%	Upgrade
Gross Profit	0	0.06	0.14	0.16	0.03	0.04	Upgrade
Selling, General & Admin	10.16	10.79	9.54	6.83	1.25	0.56	Upgrade
Research & Development	11.24	11.52	8.38	7.16	2.26	1.59	Upgrade
Operating Expenses	21.4	22.31	17.92	13.99	3.51	2.14	Upgrade
Operating Income	-21.4	-22.25	-17.78	-13.83	-3.48	-2.1	Upgrade
Interest Expense / Income	0	0	0	0	0	0.02	Upgrade
Other Expense / Income	-0.34	-0.06	-0.28	0.06	0.09	0.07	Upgrade
Pretax Income	-21.06	-22.19	-17.5	-13.89	-3.57	-2.19	Upgrade
Income Tax	0.08	0.08	0.09	0	0.01	0.01	Upgrade
Net Income	-21.14	-22.27	-17.59	-13.89	-3.58	-2.19	Upgrade
Shares Outstanding (Basic)	18	13	12	10	3	2	Upgrade
Shares Outstanding (Diluted)	18	13	12	10	3	2	Upgrade
Shares Change	50.64%	9.49%	16.90%	279.11%	19.17%	-	Upgrade
EPS (Basic)	-1.50	-1.71	-1.48	-1.37	-1.33	-0.97	Upgrade
EPS (Diluted)	-1.50	-1.71	-1.48	-1.37	-1.33	-0.97	Upgrade
Free Cash Flow	-18.24	-18.88	-14.81	-12.46	-3.26	-1.88	Upgrade
Free Cash Flow Per Share	-1.01	-1.45	-1.25	-1.23	-1.22	-0.84	Upgrade
Gross Margin	-	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-	-40328.26%	-12688.10%	-8379.80%	-12047.54%	-5084.89%	Upgrade
Profit Margin	-	-40354.33%	-12555.13%	-8418.86%	-12387.67%	-5310.88%	Upgrade
Free Cash Flow Margin	-	-34217.53%	-10571.20%	-7551.72%	-11291.38%	-4557.35%	Upgrade
EBITDA	-20.98	-22.1	-17.43	-13.87	-3.56	-2.16	Upgrade
EBITDA Margin	-	-40059.20%	-12442.97%	-8407.04%	-12335.81%	-5237.69%	Upgrade
Depreciation & Amortization	0.08	0.08	0.06	0.02	0.01	0	Upgrade
EBIT	-21.06	-22.19	-17.5	-13.89	-3.57	-2.17	Upgrade
EBIT Margin	-	-40210.67%	-12488.77%	-8416.43%	-12369.02%	-5243.92%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).